SVA [SINOVAC BIOTECH] 6-K: SEC Concludes Investigation of Sinovac About Sinovac Sinovac

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-08-20
Original SEC Filing: Click here


Webplus: SVA/20180820/6-K/2_EX-99.1/000.htm SEC Original: tv501368_ex99-1.htm
SEC Concludes Investigation of Sinovac About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac’s product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps. Healive, the




Webplus: SVA/20180820/6-K/1/000.htm SEC Original: tv501368_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-08-20CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200

Home Page Forums

By | 2018-08-21T03:36:34+00:00 August 20th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar